[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368416-105":59,"doc-detail-368416-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","stabilization-of-gtse1-by-cyclin-d1-cdk46-mediated-phosphorylation-promotes-cell-proliferation-with-implications-for-cancer-prognosis","Stabilization of GTSE1 by cyclin D1 - CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis","","In healthy cells, cyclin D1 functions during the G1 phase by activating CDK4 and CDK6, and its dysregulation is a known oncogenic driver in many human cancers. Using an integrative approach of bioinformatic analyses and biochemical experiments, the study identifies GTSE1 (G-Two and S phases expressed protein 1) as a previously unrecognized substrate of cyclin D1–CDK4/6 in tumor cells overexpressing cyclin D1 across G1 and subsequent phases. Cyclin D1–CDK4/6 phosphorylation blocks GTSE1 degradation, elevating GTSE1 throughout the cell cycle, promoting proliferation, and correlating with poor prognosis in pan-cancer datasets. The findings expand cyclin D1’s role in cell-cycle control and oncogenesis beyond RB phosphorylation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stabilization-of-gtse1-by-cyclin-d1-cdk46-mediated-phosphorylation-promotes-cell-proliferation-with-implications-for-cancer-prognosis/368416/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stabilization-of-gtse1-by-cyclin-d1-cdk46-mediated-phosphorylation-promotes-cell-proliferation-with-implications-for-cancer-prognosis/368416.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does cyclin D1 play in normal cell-cycle progression?","Question",{"text":112,"@type":113},"Cyclin D1 is expressed during the G1 phase and activates CDK4 and CDK6, driving progression through the cell cycle.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is GTSE1 identified as in this study?",{"text":117,"@type":113},"GTSE1 is characterized as a previously unrecognized substrate of the cyclin D1–CDK4/6 axis in tumor cells overexpressing cyclin D1.",{"name":119,"@type":110,"acceptedAnswer":120},"How does cyclin D1–CDK4/6 phosphorylation affect GTSE1 and what is the biological outcome?",{"text":121,"@type":113},"Phosphorylation inhibits GTSE1 degradation, leading to high GTSE1 levels across cell-cycle phases, which promotes cellular proliferation and associates with poor cancer prognosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368416,1790536498,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","RESEARCH ARTICLE  \n*For correspondence:  \n[sharon.kaisari@nyulangone.org](sharon.kaisari@nyulangone.org)[ ](sharon.kaisari@nyulangone.org)(SK);  \nmichele.pagano@nyulangone. org (MP)  \nPresent address: †Arvinas Inc, New Haven, United States  \nCompeting interest: See page 14  \nFunding: See page 14  \nPreprint posted  \n29 June 2024  \nSent for Review  \n15 July 2024  \nReviewed preprint posted  \n20 September 2024  \nReviewed preprint revised  \n26 March 2025  \nVersion of Record published  \n24 April 2025  \nReviewing Editor: Ivan Topisirovic, McGill University, Canada  \n Copyright García-Vázquez et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.  \nStabilization of GTSE1 by cyclin D1– CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis  \nNelson García-Vázquez1, Tania J González-Robles1,2,3, Ethan Lane1,  \nDaria Spasskaya1, Qingyue Zhang1, Marc A Kerzhnerman1, YeonTae Jeong1†, Marta Collu1, Daniele Simoneschi1, Kelly V Ruggles2, Gergely Róna1,3,4, Sharon Kaisari1,3*, Michele Pagano1,3*  \n1 Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States; 2 Department of Medicine, New York University Grossman School of Medicine, New York, United States; 3 Howard Hughes Medical Institute, New York University Grossman School of Medicine, New York, United States; 4 Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary  \n\n| eLife Assessment\u003Cbr>In this article, García-Vázquez et al. report valuable findings demonstrating that G2 and S phases expressed protein 1 (GTSE1), is a previously unappreciated non-pocket substrate of the cyclin D/ cyclin-dependent kinase (CDK) 4/6 axis. The authors provide convincing evidence showing that this mechanism is triggered in pathological states in which cyclin D levels are elevated (e.g., cancer) . Overall, this study holds a promise to improve understanding of the mechanisms underpinning cell cycle progression including its dysregulation in neoplasia and may thus be of broad interest to researchers belonging to diverse biomedical disciplines ranging from cancer research to cell biology. |\n| --- |\n| Abstract In healthy cells, cyclin D1 is expressed during the G1 phase of the cell cycle, where it activates CDK4 and CDK6 . Its dysregulation is a well-established oncogenic driver in numerous human cancers. The cancer-related function of cyclin D1 has been primarily studied by focusing on the phosphorylation of the retinoblastoma (RB) gene product. Here, using an integrative approach combining bioinformatic analyses and biochemical experiments, we show that GTSE1 (G-Two and S phases expressed protein 1), a protein positively regulating cell cycle progression, is a previously unrecognized substrate of cyclin D1–CDK4/6 in tumor cells overexpressing cyclin D1 during G1 and subsequent phases. The phosphorylation of GTSE1 mediated by cyclin D1–CDK4/6 inhibits GTSE1 degradation, leading to high levels of GTSE1 across all cell cycle phases. Functionally, the phosphorylation of GTSE1 promotes cellular proliferation and is associated with poor prognosis within a pan-cancer cohort. Our findings provide insights into cyclin D1’s role in cell cycle control and oncogenesis beyond RB phosphorylation. |\n\nGarcía-Vázquez et al. eLife 2024;13:RP101075. DOI: [https://doi.org/10.7554/eLife.101075](https://doi.org/10.7554/eLife.101075) 1 of 17  \n Research article Biochemistry and Chemical Biology  \nIntroduction  \nD-type cyclins (cyclin D1, cyclin D2, and cyclin D3) are activators of the cyclin-dependent kinases CDK4 and CDK6 and represent major oncogenic drivers among members of the cyclin superfamily (Musgrove et al., 2011; Fassl et al., 2022; Álvarez-Fernández and Malumbres, 2020; Behan et al., 2019) . The CCND1 gene --encoding ","cbCaiaQaJGwcanTD","https://ap.wps.com/l/cbCaiaQaJGwcanTD","pdf",7721356,17,"English","# Introduction\n## D-type cyclins and CDK4/6 oncogenic drivers\n## Known substrate framework centered on RB/E2F\n## Rationale for identifying additional GTSE1 substrates\n# Abstract","[{\"question\":\"What role does cyclin D1 play in normal cell-cycle progression?\",\"answer\":\"Cyclin D1 is expressed during the G1 phase and activates CDK4 and CDK6, driving progression through the cell cycle.\"},{\"question\":\"What is GTSE1 identified as in this study?\",\"answer\":\"GTSE1 is characterized as a previously unrecognized substrate of the cyclin D1–CDK4/6 axis in tumor cells overexpressing cyclin D1.\"},{\"question\":\"How does cyclin D1–CDK4/6 phosphorylation affect GTSE1 and what is the biological outcome?\",\"answer\":\"Phosphorylation inhibits GTSE1 degradation, leading to high GTSE1 levels across cell-cycle phases, which promotes cellular proliferation and associates with poor cancer prognosis.\"}]","Stabilization of GTSE1 by cyclin D1 - CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis | PDF",1790176856,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3eb2e564d978d97f9fa1eab5e4b5edbf.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05766ed8737220c0dc725bf9eb74da2a.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/615ab6ef2f1afed722473e19a66d58fd.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13fbb4cdf7452091cf2a17f959135f4e.webp",980,1268]